Lawrence Saperstein

1.2k total citations · 2 hit papers
33 papers, 823 citations indexed

About

Lawrence Saperstein is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Lawrence Saperstein has authored 33 papers receiving a total of 823 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pulmonary and Respiratory Medicine, 17 papers in Radiology, Nuclear Medicine and Imaging and 7 papers in Oncology. Recurrent topics in Lawrence Saperstein's work include Prostate Cancer Treatment and Research (16 papers), Radiopharmaceutical Chemistry and Applications (13 papers) and Prostate Cancer Diagnosis and Treatment (8 papers). Lawrence Saperstein is often cited by papers focused on Prostate Cancer Treatment and Research (16 papers), Radiopharmaceutical Chemistry and Applications (13 papers) and Prostate Cancer Diagnosis and Treatment (8 papers). Lawrence Saperstein collaborates with scholars based in United States, Canada and Germany. Lawrence Saperstein's co-authors include Frédéric Pouliot, Barry A. Siegel, Michael A. Gorin, Michael J. Morris, Peter R. Carroll, Vivien Wong, Steven P. Rowe, Nancy Stambler, Jessica Jensen and Tess Lin and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and NeuroImage.

In The Last Decade

Lawrence Saperstein

32 papers receiving 807 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Phase 2/3 Prospective Multicenter Study of the Diagnostic Accuracy of Prostate Specific Membrane Antigen PET/CT with ¹⁸ F-DCFPyL in Prostate Cancer Patients (OSPREY)

2021 244 citations Kenneth J. Pienta, Michael A. Gorin et al. profile →
Diagnostic Performance of 18F-DCFPyL-PET/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the CONDOR Phase III, Multicenter Study

2021 237 citations Michael J. Morris, Steven P. Rowe et al. Clinical Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lawrence Saperstein United States	11	537	353	134	124	108	33	823
Mathias J. Zacherl Germany	13	282 0.5×	348 1.0×	196 1.5×	84 0.7×	35 0.3×	54	682
Jae Seon Eo South Korea	19	236 0.4×	449 1.3×	131 1.0×	114 0.9×	147 1.4×	55	902
Rojymon Jacob United States	18	604 1.1×	283 0.8×	239 1.8×	235 1.9×	86 0.8×	70	1.1k
J.Y. Herry France	13	141 0.3×	231 0.7×	69 0.5×	108 0.9×	174 1.6×	32	680
Bong‐Il Song South Korea	19	222 0.4×	463 1.3×	184 1.4×	167 1.3×	118 1.1×	46	815
S. Gerum Germany	14	293 0.5×	186 0.5×	342 2.6×	424 3.4×	174 1.6×	32	1.1k
Annika Herlemann Germany	18	785 1.5×	233 0.7×	149 1.1×	149 1.2×	11 0.1×	75	1.1k
Remge M. Pieterman Netherlands	10	883 1.6×	650 1.8×	148 1.1×	74 0.6×	14 0.1×	13	1.1k
Judy Schwimmer United States	8	166 0.3×	329 0.9×	299 2.2×	78 0.6×	92 0.9×	8	652
Jeffrey T. Lenert United States	13	240 0.4×	69 0.2×	148 1.1×	230 1.9×	53 0.5×	17	623

Countries citing papers authored by Lawrence Saperstein

Since Specialization

Citations

This map shows the geographic impact of Lawrence Saperstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lawrence Saperstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lawrence Saperstein more than expected).

Fields of papers citing papers by Lawrence Saperstein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lawrence Saperstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lawrence Saperstein. The network helps show where Lawrence Saperstein may publish in the future.

Co-authorship network of co-authors of Lawrence Saperstein

This figure shows the co-authorship network connecting the top 25 collaborators of Lawrence Saperstein. A scholar is included among the top collaborators of Lawrence Saperstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lawrence Saperstein. Lawrence Saperstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kunst, Natalia, Jessica B. Long, Preston Sprenkle, et al.. (2024). Long-Term Outcomes of Prostate-Specific Membrane Antigen–PET Imaging of Recurrent Prostate Cancer. JAMA Network Open. 7(10). e2440591–e2440591. 3 indexed citations

Leapman, Michael, Jessica B. Long, Preston Sprenkle, et al.. (2024). Temporal and regional patterns of prostate cancer positron emission tomography imaging among commercial insurance beneficiaries in the United States.. Journal of Clinical Oncology. 42(4_suppl). 34–34. 1 indexed citations

Pouliot, Frédéric, Michael A. Gorin, Steven P. Rowe, et al.. (2023). Changes in planned disease management after piflufolastat F¹⁸ PET/CT in men with biochemically recurrent prostate cancer and low PSA levels: A secondary analysis of results from the CONDOR study.. Journal of Clinical Oncology. 41(6_suppl). 61–61. 1 indexed citations

Morris, Michael J., Steven P. Rowe, Michael A. Gorin, et al.. (2021). Diagnostic Performance of 18F-DCFPyL-PET/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the CONDOR Phase III, Multicenter Study. Clinical Cancer Research. 27(13). 3674–3682. 237 indexed citations breakdown →

Liu, Hui, MingDe Lin, David Ménard, et al.. (2021). PET Image Denoising Using a Deep-Learning Method for Extremely Obese Patients. IEEE Transactions on Radiation and Plasma Medical Sciences. 6(7). 766–770. 10 indexed citations

Uezono, Haruka, et al.. (2021). Clinical PET/CT utilization during the COVID-19 pandemic: initial experience at Yale University. Nuclear Medicine Communications. 42(11). 1277–1284. 2 indexed citations

Durack, Jeremy C., Ajjai Alva, Mark A. Preston, et al.. (2021). A prospective phase II/III study of PSMA-targeted 18F-DCFPyL-PET/CT in patients (pts) with prostate cancer (PCa) (OSPREY): A subanalysis of disease staging changes in PCa pts with recurrence or metastases on conventional imaging.. Journal of Clinical Oncology. 39(6_suppl). 32–32. 2 indexed citations

Schobert, Isabel, Julius Chapiro, Darko Pucar, Lawrence Saperstein, & Lynn Jeanette Savic. (2019). Fluorodeoxyglucose PET for Monitoring Response to Embolotherapy (Transarterial Chemoembolization) in Primary and Metastatic Liver Tumors. PET Clinics. 14(4). 437–445. 3 indexed citations

Schobert, Isabel, Julius Chapiro, Nariman Nezami, et al.. (2019). Quantitative Imaging Biomarkers for⁹⁰Y Distribution on Bremsstrahlung SPECT After Resin-Based Radioembolization. Journal of Nuclear Medicine. 60(8). 1066–1072. 5 indexed citations

10.

Pucar, Darko, et al.. (2018). Superior Pituitary Border Analysis in Immunotherapy-Induced Hypophysitis. Clinical Nuclear Medicine. 43(4). 284–286. 4 indexed citations

11.

Morris, Michael J., Peter R. Carroll, Stephan Probst, et al.. (2018). A prospective phase 2/3 multicenter study of ¹⁸F-DCFPyL PET/CT imaging in patients with prostate cancer: Examination of diagnostic accuracy (OSPREY).. Journal of Clinical Oncology. 36(15_suppl). TPS5092–TPS5092. 3 indexed citations

12.

Tagare, Hemant D., et al.. (2017). Voxel-based logistic analysis of PPMI control and Parkinson's disease DaTscans. NeuroImage. 152. 299–311. 24 indexed citations

13.

Pucar, Darko, et al.. (2017). Molecular imaging of prostate cancer. British Journal of Radiology. 91(1084). 20170736–20170736. 17 indexed citations

14.

Semba, Charles P., Lawrence Saperstein, Ulf Nyman, & Michael D. Dake. (1996). Hepatic Laceration from Wedged Venography Performed before Transjugular Intrahepatic Portosystemic Shunt Placement. Journal of Vascular and Interventional Radiology. 7(1). 143–146. 51 indexed citations

15.

Saperstein, Lawrence, et al.. (1994). Transforming growth factor-beta 1 and mannose 6-phosphate/insulin-like growth factor-II receptor expression during intrahepatic bile duct hyperplasia and biliary fibrosis in the rat.. PubMed. 19(2). 412–7. 55 indexed citations

16.

Thomson, Hugh G., Katherine B. Kisslo, Marwan Farouk, et al.. (1993). Technique of intraluminal biliary ultrasonography during laparoscopic cholecystectomy. The American Journal of Surgery. 165(2). 265–269. 11 indexed citations

17.

Geoghegan, Justin, M Farouk, Lawrence Saperstein, et al.. (1993). Exogenous Neuropeptide Y Blocks Myoelectric Activity in the Upper Gastrointestinal Tract of Starved Dogs: Brain Neuropeptide Y Converts a Fasting Pattern of Myoelectric Activity to a Fed Pattern. Scandinavian Journal of Gastroenterology. 28(6). 469–474. 10 indexed citations

18.

Saperstein, Lawrence, David Kucharski, Mark E. Stanton, & W. G. Hall. (1989). Developmental change in reversal learning of an olfactory discrimination. Psychobiology. 17(3). 293–299. 10 indexed citations

19.

Saperstein, Lawrence, et al.. (1980). Total intestinal aganglionosis.. PubMed. 47(1). 72–3. 5 indexed citations

20.

Saperstein, Lawrence, et al.. (1979). A review of 814 cases of biliary tract surgery from 1957-1977.. PubMed. 46(2). 243–6. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact